Prokarium Receives UK Grant for Development of Oral Vaccine
Vaccine developer Prokarium has been awarded £400,000 ($600,000) to help develop an oral vaccine.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Vaccine developer Prokarium has been awarded £400,000 ($600,000) to help develop an oral vaccine.